Medications

Terlipressin bests placebo in type 1 hepatorenal syndrome

(HealthDay)—For patients with type 1 hepatorenal syndrome (HRS-1), terlipressin is more effective than placebo for reversal of HRS, according to a study published in the March 4 issue of the New England Journal of Medicine.

Oncology & Cancer

Armoring anti-cancer T cells against immunosuppressants

Duke-NUS Medical School researchers, together with collaborators in Singapore, have designed armored immune cells that can attack recurring cancer in liver transplant patients, while temporarily evading immunosuppressant ...

Diseases, Conditions, Syndromes

Alcohol fuels surge in chronic liver disease

Alcohol's popularity and its central place in socializing in Australia obscures the dangers of excessive drinking and possible liver disease, Flinders University experts warn.

Diseases, Conditions, Syndromes

Liver surgery success boosted by growth hormone

Growth hormone has been identified as playing a key role in reducing inflammation and increasing survival rates following liver surgery.

Medications

Study finds new option for liver transplant patients

A drug commonly used to treat both asthma and inflammatory bowel disease, budesonide, may also be useful as an anti-organ rejection medication for liver transplant patients leading to fewer serious side effects than the most ...

Diseases, Conditions, Syndromes

Liver transplants double for alcohol-related liver disease

The proportion of U.S. liver transplants for alcohol-associated liver disease (ALD) has doubled in the last 15 years, in part due to broader acceptance of waiving the mandated period of sobriety before transplants for this ...

page 1 from 6